Ascendis Pharma A (ASND) EBT Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 79.15% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 21.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.74% |
| Dec 31, 2025 | 46.77% |
| Sep 30, 2025 | 26.73% |
| Jun 30, 2025 | 23.01% |
| Mar 31, 2025 | 11.21% |
| Dec 31, 2024 | 30.97% |
| Sep 30, 2024 | -4.40% |
| Jun 30, 2024 | 10.12% |
| Mar 31, 2024 | -22.49% |
| Dec 31, 2023 | 19.25% |
| Sep 30, 2023 | -7.34% |
| Jun 30, 2023 | -8.23% |
| Mar 31, 2023 | -18.91% |
| Dec 31, 2022 | -32.32% |
| Sep 30, 2022 | -82.59% |
| Jun 30, 2022 | -9.43% |
| Mar 31, 2022 | -32.06% |
| Dec 31, 2021 | -49.16% |
| Sep 30, 2021 | -33.72% |
| Jun 30, 2021 | -81.01% |